Diabetes Technology & Therapeutics Issues Research Articles in September 2024 Edition
September 05, 2024
September 05, 2024
NEW ROCHELLE, New York, Sept. 5 -- Diabetes Technology and Therapeutics, a peer-reviewed journal that says it covers all aspects of diagnosing and managing diabetes with cutting-edge devices, drugs, drug delivery systems and software, published research articles on the following topics in its September 2024 edition (Vol. 26, Issue 9):
Original Articles
* Beta-Hydroxybutyrate Levels and Risk of Diabetic Ketoacidosis in Adults with Type 1 Diabetes Treated with Sotaglifloz . . .
Original Articles
* Beta-Hydroxybutyrate Levels and Risk of Diabetic Ketoacidosis in Adults with Type 1 Diabetes Treated with Sotaglifloz . . .